Skip all navigation and go to page content
NN/LM Home About MAR | Contact MAR | Feedback | Help | Bookmark and Share

Archive for the ‘Clinical Alerts’ Category

Patient Safety Awareness

Friday, February 26th, 2016

Submitted by: Network and Advocacy Coordinator Michelle Burda

The United for Patient Safety campaign, initiated by National Patient Safety Foundation, highlights and reinforces the fact that everyone plays a role in keeping patients safe and free from harm.

Boston’s Brigham and Women’s Hospital is publicly sharing stories about medical errors made at the hospital in a blog, Safety Matters, with the intention that this will help reduce the risk of future mistakes.

Patient Safety Awareness Week will be observed this year March 13-19 with an emphasis on the message that “every day is patient safety day.”  Participate in the webcast, Patient Safety is a Public Health Issue Thursday March 17, 2016, 1:00 PM ET with national leaders in Patient Safety.

New Clinical Advisory Issued by National Heart, Lung, and Blood Institute

Thursday, May 29th, 2014

The National Institutes of Health’s National Heart, Lung, and Blood Institute has suspended enrollment for the clinical study BMT CTN 0901 conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) after preliminary data appeared to show benefit for one approach to the intensity of conditioning for allogeneic stem cell transplantations in patients eligible for the study: http://www.nlm.nih.gov/pubs/techbull/mj14/brief/ma14_clinical_advisory.html

Clinical Advisory from NHLBI

Saturday, May 17th, 2014

A clinical advisory from NHLBI was issued. Information is now available on several NLM websites.

·        NLM Homepage under “News & Events”

·        NIH Clinical Alerts and Advisories page: http://www.nlm.nih.gov/databases/alerts/clinical_alerts.html

·        Technical Bulletin: http://www.nlm.nih.gov/pubs/techbull/tb.html (under “In Brief”)

·        Direct link to the alert: http://www.nlm.nih.gov/databases/alerts/2014_nhlbi_bmt_ctn.html

New Clinical Alert

Thursday, November 3rd, 2011

Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful NIH stops one treatment arm of trial; other two treatments to continue:  http://www.nlm.nih.gov/databases/alerts/2011_nhlbi_ifp.html.